全文获取类型
收费全文 | 5528篇 |
免费 | 515篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 139篇 |
妇产科学 | 118篇 |
基础医学 | 804篇 |
口腔科学 | 113篇 |
临床医学 | 500篇 |
内科学 | 1255篇 |
皮肤病学 | 244篇 |
神经病学 | 446篇 |
特种医学 | 180篇 |
外国民族医学 | 3篇 |
外科学 | 863篇 |
综合类 | 31篇 |
预防医学 | 426篇 |
眼科学 | 119篇 |
药学 | 402篇 |
中国医学 | 20篇 |
肿瘤学 | 320篇 |
出版年
2023年 | 31篇 |
2022年 | 62篇 |
2021年 | 164篇 |
2020年 | 124篇 |
2019年 | 183篇 |
2018年 | 204篇 |
2017年 | 147篇 |
2016年 | 164篇 |
2015年 | 151篇 |
2014年 | 195篇 |
2013年 | 243篇 |
2012年 | 354篇 |
2011年 | 355篇 |
2010年 | 210篇 |
2009年 | 180篇 |
2008年 | 285篇 |
2007年 | 255篇 |
2006年 | 271篇 |
2005年 | 242篇 |
2004年 | 184篇 |
2003年 | 193篇 |
2002年 | 170篇 |
2001年 | 165篇 |
2000年 | 147篇 |
1999年 | 126篇 |
1998年 | 42篇 |
1997年 | 47篇 |
1996年 | 46篇 |
1995年 | 41篇 |
1994年 | 46篇 |
1993年 | 39篇 |
1992年 | 136篇 |
1991年 | 114篇 |
1990年 | 79篇 |
1989年 | 66篇 |
1988年 | 64篇 |
1987年 | 55篇 |
1986年 | 69篇 |
1985年 | 64篇 |
1984年 | 39篇 |
1983年 | 30篇 |
1982年 | 28篇 |
1981年 | 21篇 |
1979年 | 18篇 |
1978年 | 25篇 |
1976年 | 18篇 |
1974年 | 19篇 |
1971年 | 15篇 |
1970年 | 16篇 |
1969年 | 21篇 |
排序方式: 共有6051条查询结果,搜索用时 15 毫秒
171.
Martha Cristina Sanchez Rani Sebti Patrice Hassoun Ciaran Mannion Andre H. Goy Tatyana Feldman Anthony Mato Tao Hong 《Journal of clinical microbiology》2013,51(8):2791-2793
A 51-year-old man with a history of stage IV angioimmunoblastic T-cell lymphoma was diagnosed with osteomyelitis of the patella. Legionella anisa was identified by 16S rRNA gene sequencing and culture. The patient had pneumonia 2 months prior to this osteomyelitis episode. L. anisa was retrospectively detected in his lung tissue by 16S rRNA gene sequencing and was considered the source of the L. anisa that caused his patella osteomyelitis. 相似文献
172.
IntroductionExtravasation or partial extravasation of the positron emission tomography (PET) tracer negatively effects image quality in PET and the accuracy of the standard uptake value (SUV). A commercially available topical sensor has been validated using a number of metrics to characterise injection quality. This evaluation explores contributing factors for extravasation and refines metrics to predict extravasation based on the time-activity-curves (TAC) of the topical sensor device.MethodsA multi-site, multi-national pooling of 18F FDG PET/CT data was undertaken with 863 patients from 6 sites in the USA and 2 sites in Australia. A number of dose migration metrics determined with topical application of Lara sensors were retrospectively analysed using conventional statistical analysis. Deeper insights into the complex relationship between variables was further explored using an artificial neural network.ResultsExtravasation was independently predicted by the time taken for the injection sensor counts to reach double the counts of the reference sensor (tc50), the normalised difference between injection and reference sensors counts at 4 min post injection (ndAvgN), or the ratio of injection sensor counts to reference sensor counts at the end of data collection (CEnd ratio). The algorithm developed using the artificial neural network produced 100% sensitivity and 100% specificity against grounded truth for detecting extravasation by weighting and scaling these 3 key metrics; CEnd ratio, ndAvgN and tc50.ConclusionPartial extravasation of a PET dose is readily detected and differentiated using TAC metrics and these metrics could provide deeper insight into the impact of partial extravasation on image quality or quantitation. Further validation of key metrics developed in this study are recommended in a larger and more diverse cohort.Implications for practicePartial extravasation undermines image quality and accuracy of quantitation, impacting efficacy of outcomes for patients. Characterisation of extravasation informs decision making to optimise protocol and procedure, enhancing patient outcomes. Awareness provides the opportunity for education and training to minimise impact. The information can be used to drive policy and regulations to support improved techniques in practice. 相似文献
173.
Aurora Moreno Flores Luis Miguel Bernal-García Juan Pablo Sosa Cabezas María Hidalgo Llorca José Antonio Rodriguez Sanchez 《Neurocirugía (Asturias, Spain)》2021,32(2):89-93
Gangliogliomas are well-differentiated, slow-growing tumors. The majority are grade I of WHO. It appears predominantly in children and young adults. Most are located at the temporal lobe, and as symptomatology more frequent epileptic seizures of difficult pharmacological control. In general, they have a good prognosis after surgical resection. The anaplasic variant, considered to be grade III of the WHO, presents greater clinical and radiological aggressiveness. Leptomeningeal dissemination is exceptional in these types of tumors, but when diagnosed it presents a rapidly progressive and fatal course for the patient. 相似文献
174.
175.
176.
Lisa L. Maher S. Lale Tokgözoğlu Eduardo J. Sanchez James A. Underberg John R. Guyton 《Journal of clinical lipidology》2021,15(3):387-393
Lipoprotein(a) operates in causal pathways to promote atherosclerosis, arterial thrombosis, and aortic stenosis. It has been associated with rare cases of nonatherosclerotic arterial thrombotic stroke at any age. Inherited variation of lipoprotein(a) levels substantially increases cardiovascular risk in 20% of people worldwide. Recent progress in identifying the risk associated with lipoprotein(a) and in pursuing effective treatment has led to a recent Global Think Tank including representatives from the European Atherosclerosis Society, American Heart Association, Preventive Cardiovascular Nurses Association, National Lipid Association, and other groups. The need for standardized laboratory measurement in nanomoles per liter met with unanimous consensus. Atherosclerotic risk is linearly associated with plasma lipoprotein(a) levels, so that persons with the highest levels may have risk similar to other severe inherited lipoprotein disorders. Universal once-in-lifetime screening has been recommended by European and Canadian cardiovascular societies, but not by U.S. organizations. Current pharmacologic therapies are limited to 20-30% lowering of lipoprotein(a) levels, and no pharmacologic treatment for lowering lipoprotein(a) has yet been proven to reduce risk in a cardiovascular outcomes trial. Treatment for high-risk patients focuses on reducing low density lipoprotein cholesterol and other risk factors. New therapies targeting messenger RNA for apolipoprotein(a) can achieve 80-90% reduction of lipoprotein(a) levels. One such therapy using a liver-directed antisense oligonucleotide is currently being tested in a large cardiovascular outcomes trial. Increased recognition of lipoprotein(a)-associated risk and emergence of potentially effective therapy together lead to a mandate for a unified global effort on education, standardization, and clinical management. 相似文献
177.
178.
Jürgen Rehm Carolin Kilian Carina Ferreira‐Borges David Jernigan Maristela Monteiro Charles D. H. Parry Zila M. Sanchez Jakob Manthey 《Drug and alcohol review》2020,39(4):301-304
Based on a literature search undertaken to determine the impacts of past public health crises, and a systematic review of the effects of past economic crises on alcohol consumption, two main scenarios—with opposite predictions regarding the impact of the current COVID‐19 pandemic on the level and patterns of alcohol consumption—are introduced. The first scenario predicts an increase in consumption for some populations, particularly men, due to distress experienced as a result of the pandemic. A second scenario predicts the opposite outcome, a lowered level of consumption, based on the decreased physical and financial availability of alcohol. With the current restrictions on alcohol availability, it is postulated that, for the immediate future, the predominant scenario will likely be the second, while the distress experienced in the first may become more relevant in the medium‐ and longer‐term future. Monitoring consumption levels both during and after the COVID‐19 pandemic will be necessary to better understand the effects of COVID‐19 on different groups, as well as to distinguish them from those arising from existing alcohol control policies. 相似文献
179.
Effects of Cardiopulmonary Support With a Novel Pediatric Pump‐Lung in a 30‐Day Ovine Animal Model
下载免费PDF全文
![点击此处可从《Artificial organs》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Yang Liu Pablo G. Sanchez Xufeng Wei Amelia C. Watkins Shuqiong Niu Zhongjun J. Wu Bartley P. Griffith 《Artificial organs》2015,39(12):989-997
The scarcity of donor organs has led to the development of devices that provide optimal long‐term respiratory or cardiopulmonary support to bridge recipients as they wait for lung and/or heart transplantation. This study was designed to evaluate the 30‐day in vivo performance of the newly developed pediatric pump‐lung (PediPL) for cardiopulmonary support using a juvenile sheep model. The PediPL device was placed surgically between the right atrium and descending aorta in eight sheep (25.4–31.2 kg) and evaluated for 30 days. Anticoagulation was maintained with continuous heparin infusion (activated clotting time 150–200 s). The flow rate was measured continually, and gas transfer was measured daily. Plasma free hemoglobin, platelet activation, hematologic data, and blood biochemistry were assessed twice a week. Sheep were euthanized after 30 days. The explanted devices were examined for gross thrombosis. Six sheep survived for 30–32 days. During the study, the oxygen transfer rate of the devices was 54.9 ± 13.2 mL/min at a mean flow rate of 1.14 ± 0.46 L/min with blood oxygen saturation of 95.4% ± 1.7%. Plasma free hemoglobin was 8.2 ± 3.7 mg/dL. Platelet activation was 5.35 ± 2.65%. The animals had normal organ chemistries except for surgery‐related transient alterations in kidney and liver function. Although we found some scattered thrombi on the membrane surfaces of some explanted devices during the necropsy, the device function and performance did not degrade. The PediPL device was capable of providing cardiopulmonary support with long‐term reliability and good biocompatibility over the 30‐day duration and offers the potential option for bridging pediatric patients with end‐stage heart or lung disease to heart and/or lung transplantation. 相似文献
180.
Arjun Sivaraman Rafael Sanchez‐Salas Eric Barret Youness Ahallal Francois Rozet Marc Galiano Dominique Prapotnich Xavier Cathelineau 《International journal of urology》2015,22(2):146-151
Accurate diagnosis of prostate cancer has eluded clinicians for decades. With our current understanding of prostate cancer, urologists should devise and confidently present the available treatment options – active surveillance/radical treatment/focal therapy to these patients. The diagnostic modalities used for prostate cancer have the dual problem of false negativity and overdiagnosis. Various modifications in the prostate biopsy techniques have increased the accuracy of cancer detection, but we are still far from an ideal diagnostic technique. Transperineal template‐guided mapping biopsy of the prostate is an exhaustive biopsy technique that has been improvised over the past decade, and has shown superior results to other available modalities. We have carried out a PubMed search on the available experiences on this diagnostic modality, and along with our own experiences, we present a brief review on transperineal template‐guided mapping biopsy of the prostate. 相似文献